vs
Heritage Insurance Holdings, Inc.（HRTG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Heritage Insurance Holdings, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.0倍（$215.3M vs $207.3M），Heritage Insurance Holdings, Inc.净利率更高（31.0% vs -62.0%，领先93.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 2.4%），Heritage Insurance Holdings, Inc.自由现金流更多（$174.2M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.1%）
该公司是一家位于美国佛罗里达州的财产意外保险公司，在美国多个沿海州开展业务，主要为客户提供商业保险、住宅保险、房主保险以及洪水保险等各类财产意外保障产品。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HRTG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.3M | $207.3M |
| 净利润 | $66.7M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 41.6% | -54.7% |
| 净利率 | 31.0% | -62.0% |
| 营收同比 | 2.4% | 25.9% |
| 净利润同比 | 228.6% | 3.5% |
| 每股收益（稀释后） | $2.15 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $215.3M | $207.3M | ||
| Q3 25 | $212.5M | $159.9M | ||
| Q2 25 | $208.0M | $166.5M | ||
| Q1 25 | $211.5M | $139.3M | ||
| Q4 24 | $210.3M | $164.6M | ||
| Q3 24 | $211.8M | $139.5M | ||
| Q2 24 | $203.6M | $147.0M | ||
| Q1 24 | $191.3M | $108.8M |
| Q4 25 | $66.7M | $-128.6M | ||
| Q3 25 | $50.4M | $-180.4M | ||
| Q2 25 | $48.0M | $-115.0M | ||
| Q1 25 | $30.5M | $-151.1M | ||
| Q4 24 | $20.3M | $-133.2M | ||
| Q3 24 | $8.2M | $-133.5M | ||
| Q2 24 | $18.9M | $-131.6M | ||
| Q1 24 | $14.2M | $-170.7M |
| Q4 25 | 41.6% | -54.7% | ||
| Q3 25 | 33.0% | -106.9% | ||
| Q2 25 | 31.2% | -64.8% | ||
| Q1 25 | 20.1% | -102.6% | ||
| Q4 24 | 15.0% | -74.3% | ||
| Q3 24 | 5.5% | -94.6% | ||
| Q2 24 | 13.6% | -79.1% | ||
| Q1 24 | 11.9% | -151.9% |
| Q4 25 | 31.0% | -62.0% | ||
| Q3 25 | 23.7% | -112.8% | ||
| Q2 25 | 23.1% | -69.0% | ||
| Q1 25 | 14.4% | -108.5% | ||
| Q4 24 | 9.7% | -80.9% | ||
| Q3 24 | 3.8% | -95.7% | ||
| Q2 24 | 9.3% | -89.5% | ||
| Q1 24 | 7.4% | -156.8% |
| Q4 25 | $2.15 | $-1.28 | ||
| Q3 25 | $1.63 | $-1.81 | ||
| Q2 25 | $1.55 | $-1.17 | ||
| Q1 25 | $0.99 | $-1.57 | ||
| Q4 24 | $0.66 | $-1.34 | ||
| Q3 24 | $0.27 | $-1.40 | ||
| Q2 24 | $0.61 | $-1.52 | ||
| Q1 24 | $0.47 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $559.3M | $421.0M |
| 总债务越低越好 | $78.4M | — |
| 股东权益账面价值 | $505.3M | $-80.0M |
| 总资产 | $2.2B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
| Q4 25 | $559.3M | $421.0M | ||
| Q3 25 | $560.4M | $202.5M | ||
| Q2 25 | $473.5M | $176.3M | ||
| Q1 25 | $425.9M | $127.1M | ||
| Q4 24 | $452.7M | $174.0M | ||
| Q3 24 | $509.9M | $150.6M | ||
| Q2 24 | $480.9M | $480.7M | ||
| Q1 24 | $386.1M | $112.3M |
| Q4 25 | $78.4M | — | ||
| Q3 25 | $79.3M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $94.8M | — | ||
| Q4 24 | $116.3M | — | ||
| Q3 24 | $118.6M | — | ||
| Q2 24 | $120.8M | — | ||
| Q1 24 | $123.0M | — |
| Q4 25 | $505.3M | $-80.0M | ||
| Q3 25 | $437.3M | $9.2M | ||
| Q2 25 | $383.3M | $151.3M | ||
| Q1 25 | $329.0M | $144.2M | ||
| Q4 24 | $290.8M | $255.0M | ||
| Q3 24 | $279.3M | $346.8M | ||
| Q2 24 | $255.3M | $432.4M | ||
| Q1 24 | $234.9M | $140.3M |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.4B | $1.2B | ||
| Q2 25 | $2.5B | $1.3B | ||
| Q1 25 | $2.2B | $1.3B | ||
| Q4 24 | $2.5B | $1.5B | ||
| Q3 24 | $2.4B | $1.5B | ||
| Q2 24 | $2.6B | $1.6B | ||
| Q1 24 | $2.1B | $1.3B |
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.18× | — | ||
| Q2 25 | 0.24× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.42× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.52× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $174.2M | $-100.8M |
| 自由现金流率自由现金流/营收 | 80.9% | -48.6% |
| 资本支出强度资本支出/营收 | 3.7% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.73× | — |
| 过去12个月自由现金流最近4个季度 | $337.4M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $182.2M | $-99.8M | ||
| Q3 25 | $124.3M | $-91.4M | ||
| Q2 25 | $43.3M | $-108.3M | ||
| Q1 25 | $837.0K | $-166.5M | ||
| Q4 24 | $87.1M | $-79.3M | ||
| Q3 24 | $-13.4M | $-67.0M | ||
| Q2 24 | $152.2M | $-77.0M | ||
| Q1 24 | $4.3M | $-190.7M |
| Q4 25 | $174.2M | $-100.8M | ||
| Q3 25 | $122.7M | $-92.7M | ||
| Q2 25 | $41.8M | $-110.7M | ||
| Q1 25 | $-1.3M | $-167.8M | ||
| Q4 24 | $78.9M | $-79.5M | ||
| Q3 24 | $-16.3M | $-68.6M | ||
| Q2 24 | $149.8M | $-79.0M | ||
| Q1 24 | $4.1M | $-193.9M |
| Q4 25 | 80.9% | -48.6% | ||
| Q3 25 | 57.8% | -58.0% | ||
| Q2 25 | 20.1% | -66.5% | ||
| Q1 25 | -0.6% | -120.5% | ||
| Q4 24 | 37.5% | -48.3% | ||
| Q3 24 | -7.7% | -49.2% | ||
| Q2 24 | 73.6% | -53.7% | ||
| Q1 24 | 2.1% | -178.2% |
| Q4 25 | 3.7% | 0.5% | ||
| Q3 25 | 0.7% | 0.8% | ||
| Q2 25 | 0.7% | 1.5% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 3.9% | 0.1% | ||
| Q3 24 | 1.4% | 1.2% | ||
| Q2 24 | 1.2% | 1.4% | ||
| Q1 24 | 0.1% | 3.0% |
| Q4 25 | 2.73× | — | ||
| Q3 25 | 2.47× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | -1.64× | — | ||
| Q2 24 | 8.07× | — | ||
| Q1 24 | 0.30× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRTG
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
